NOTIFICATION OF USE
for Biological and Recombinant Work
Principal Investigators are required to submit a Notification of Use (NOU) for Biological Agents, recombinant material, Human and Non-Human Primate Products for Institutional Biosafety Committee (IBC) approval prior to any work being conducted.
Addition of new agents to existing protocol is not permitted a new NOU must be submitted.
The IBC meets each first Friday of the month. All paperwork must be provided to EHS Biosafety Program two weeks prior to the meeting by campus mail to Rt. #1111 or by email to EHS.IBC@utmb.edu. Contact the Biosafety Program at (409) 772-1781 if you have any questions.
Amendment form to existing NOU:
Keck and Optical Microscopy Core Facilities NOU Amendment Form (Revised 02-15)
Aerobiology Facility Amendment Form (Revised 02-15)
Recombinant Materials Form (Revised 05-16)
Arthropod Section Form(Revised 10-15)
Animal Section Form (Revised 12-15)
Add or delete personnel on existing NOU form (Revised 03-16)
Special Immunization request form (Use for FDA approved vaccines)
Co-PI Cover Page form (Revised 02-15)
Risk Assessment for Special Immunization Request Form 1 and Form 2 (Use for IND/Global vaccines)